Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 98 Pages
Report ld: 5501042
Request Sample
Customized Report
Closed Drug Transfer Systems Market Size(US$)

CAGR 2026-2032
18.1%
Market Size,2032
USD 3,583
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1136 million in 2025 and is projected to reach US$ 3583 million, growing at a CAGR of 18.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Closed Drug Transfer Systems cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
The rapid development of the closed-system drug transfer device market is driven by several key factors. First, there is a growing global emphasis on medical safety and sterile operations, particularly in hospitals, clinics, and other healthcare facilities. Preventing drug contamination and cross-infection has become a top priority. Closed-system drug transfer devices effectively ensure sterility during the transportation and transfer of drugs, reducing the risk of exposure to harmful substances for both healthcare workers and patients.
Second, advancements in biopharmaceuticals and personalized medicine have led to an increase in new types of drugs (such as cancer drugs and immunotherapy agents) that require highly controlled storage and transport conditions. These drugs are often highly active and sensitive, necessitating handling in controlled environments to ensure their stability and efficacy. Additionally, increasingly stringent regulations are compelling healthcare institutions to adopt more advanced transfer systems to comply with standards and guidelines, thereby avoiding potential legal risks and penalties.
In the future, the closed-system drug transfer device market will exhibit several significant trends. On one hand, technological innovation will continue to propel this field forward. For instance, the application of intelligent and automated technologies will make transfer devices more efficient, precise, and easier to manage, reducing the likelihood of human error. The integration of Internet of Things (IoT) technology allows these devices to monitor the status and environmental parameters of drugs in real-time, providing immediate feedback and alerts, which enhances supply chain transparency and traceability.
On the other hand, influenced by concepts of environmental protection and sustainability, manufacturers will place greater emphasis on the environmental performance and energy efficiency of their products. They will develop materials and technologies that are lighter, more energy-efficient, and easier to recycle. Furthermore, as the uneven distribution of global healthcare resources becomes more pronounced, the growing demand for telemedicine services will drive the use of closed-system drug transfer devices in remote areas and primary healthcare facilities, further expanding market coverage.
This report provides a comprehensive view of the global market for Closed Drug Transfer Systems, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Closed Drug Transfer Systems market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Closed Drug Transfer Systems.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Closed Drug Transfer Systems manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Closed Drug Transfer Systems sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Closed Drug Transfer Systems sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Closed Drug Transfer Systems Product Introduction
1.2 Global Closed Drug Transfer Systems Market Size Forecast
1.2.1 Global Closed Drug Transfer Systems Sales Value (2021–2032)
1.2.2 Global Closed Drug Transfer Systems Sales Volume (2021–2032)
1.2.3 Global Closed Drug Transfer Systems Sales Price (2021–2032)
1.3 Closed Drug Transfer Systems Market Trends & Drivers
1.3.1 Closed Drug Transfer Systems Industry Trends
1.3.2 Closed Drug Transfer Systems Market Drivers & Opportunities
1.3.3 Closed Drug Transfer Systems Market Challenges
1.3.4 Closed Drug Transfer Systems Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Closed Drug Transfer Systems Players Revenue Ranking (2025)
2.2 Global Closed Drug Transfer Systems Revenue by Company (2021–2026)
2.3 Global Closed Drug Transfer Systems Sales Volume Ranking of Players (2025)
2.4 Global Closed Drug Transfer Systems Sales Volume by Company (2021–2026)
2.5 Global Closed Drug Transfer Systems Average Price by Company (2021–2026)
2.6 Key Manufacturers Closed Drug Transfer Systems Manufacturing Base and Headquarters
2.7 Key Manufacturers Closed Drug Transfer Systems Product Offerings
2.8 Key Manufacturers Start of Mass Production of Closed Drug Transfer Systems
2.9 Closed Drug Transfer Systems Market Competitive Analysis
2.9.1 Closed Drug Transfer Systems Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Closed Drug Transfer Systems Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Closed Drug Transfer Systems revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Closed Drug Transfer Systems Market Classification
3.1 Introduction by Type
3.1.1 Closed Vial Access Devices
3.1.2 Closed Syringe Safety Devices
3.1.3 Closed Bag/Line Access Devices
3.1.4 Global Closed Drug Transfer Systems Sales Value by Type
3.1.4.1 Global Closed Drug Transfer Systems Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Closed Drug Transfer Systems Sales Value, by Type (2021–2032)
3.1.4.3 Global Closed Drug Transfer Systems Sales Value, by Type (%), 2021–2032
3.1.5 Global Closed Drug Transfer Systems Sales Volume by Type
3.1.5.1 Global Closed Drug Transfer Systems Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Closed Drug Transfer Systems Sales Volume, by Type (2021–2032)
3.1.5.3 Global Closed Drug Transfer Systems Sales Volume, by Type (%), 2021–2032
3.1.6 Global Closed Drug Transfer Systems Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Closed Drug Transfer Systems Sales Value by Application
4.2.1 Global Closed Drug Transfer Systems Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Closed Drug Transfer Systems Sales Value, by Application (2021–2032)
4.2.3 Global Closed Drug Transfer Systems Sales Value, by Application (%), 2021–2032
4.3 Global Closed Drug Transfer Systems Sales Volume by Application
4.3.1 Global Closed Drug Transfer Systems Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Closed Drug Transfer Systems Sales Volume, by Application (2021–2032)
4.3.3 Global Closed Drug Transfer Systems Sales Volume, by Application (%), 2021–2032
4.4 Global Closed Drug Transfer Systems Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Closed Drug Transfer Systems Sales Value by Region
5.1.1 Global Closed Drug Transfer Systems Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Closed Drug Transfer Systems Sales Value by Region (2021–2026)
5.1.3 Global Closed Drug Transfer Systems Sales Value by Region (2027–2032)
5.1.4 Global Closed Drug Transfer Systems Sales Value by Region (%), 2021–2032
5.2 Global Closed Drug Transfer Systems Sales Volume by Region
5.2.1 Global Closed Drug Transfer Systems Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Closed Drug Transfer Systems Sales Volume by Region (2021–2026)
5.2.3 Global Closed Drug Transfer Systems Sales Volume by Region (2027–2032)
5.2.4 Global Closed Drug Transfer Systems Sales Volume by Region (%), 2021–2032
5.3 Global Closed Drug Transfer Systems Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Closed Drug Transfer Systems Sales Value, 2021–2032
5.4.2 North America Closed Drug Transfer Systems Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Closed Drug Transfer Systems Sales Value, 2021–2032
5.5.2 Europe Closed Drug Transfer Systems Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Closed Drug Transfer Systems Sales Value, 2021–2032
5.6.2 Asia Pacific Closed Drug Transfer Systems Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Closed Drug Transfer Systems Sales Value, 2021–2032
5.7.2 South America Closed Drug Transfer Systems Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Closed Drug Transfer Systems Sales Value, 2021–2032
5.8.2 Middle East & Africa Closed Drug Transfer Systems Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Closed Drug Transfer Systems Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Closed Drug Transfer Systems Sales Value and Sales Volume
6.2.1 Key Countries/Regions Closed Drug Transfer Systems Sales Value, 2021–2032
6.2.2 Key Countries/Regions Closed Drug Transfer Systems Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Closed Drug Transfer Systems Sales Value, 2021–2032
6.3.2 United States Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Closed Drug Transfer Systems Sales Value, 2021–2032
6.4.2 Europe Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Closed Drug Transfer Systems Sales Value, 2021–2032
6.5.2 China Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.5.3 China Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Closed Drug Transfer Systems Sales Value, 2021–2032
6.6.2 Japan Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Closed Drug Transfer Systems Sales Value, 2021–2032
6.7.2 South Korea Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Closed Drug Transfer Systems Sales Value, 2021–2032
6.8.2 Southeast Asia Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Closed Drug Transfer Systems Sales Value, 2021–2032
6.9.2 India Closed Drug Transfer Systems Sales Value by Type (%), 2025 vs 2032
6.9.3 India Closed Drug Transfer Systems Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BD Medical, Inc
7.1.1 BD Medical, Inc Company Information
7.1.2 BD Medical, Inc Introduction and Business Overview
7.1.3 BD Medical, Inc Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BD Medical, Inc Closed Drug Transfer Systems Product Offerings
7.1.5 BD Medical, Inc Recent Developments
7.2 Equashield
7.2.1 Equashield Company Information
7.2.2 Equashield Introduction and Business Overview
7.2.3 Equashield Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Equashield Closed Drug Transfer Systems Product Offerings
7.2.5 Equashield Recent Developments
7.3 ICU Medical
7.3.1 ICU Medical Company Information
7.3.2 ICU Medical Introduction and Business Overview
7.3.3 ICU Medical Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 ICU Medical Closed Drug Transfer Systems Product Offerings
7.3.5 ICU Medical Recent Developments
7.4 Simplivia Healthcare Ltd.
7.4.1 Simplivia Healthcare Ltd. Company Information
7.4.2 Simplivia Healthcare Ltd. Introduction and Business Overview
7.4.3 Simplivia Healthcare Ltd. Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Simplivia Healthcare Ltd. Closed Drug Transfer Systems Product Offerings
7.4.5 Simplivia Healthcare Ltd. Recent Developments
7.5 Corvida Medical
7.5.1 Corvida Medical Company Information
7.5.2 Corvida Medical Introduction and Business Overview
7.5.3 Corvida Medical Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Corvida Medical Closed Drug Transfer Systems Product Offerings
7.5.5 Corvida Medical Recent Developments
7.6 B. Braun
7.6.1 B. Braun Company Information
7.6.2 B. Braun Introduction and Business Overview
7.6.3 B. Braun Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 B. Braun Closed Drug Transfer Systems Product Offerings
7.6.5 B. Braun Recent Developments
7.7 Yukon Medical
7.7.1 Yukon Medical Company Information
7.7.2 Yukon Medical Introduction and Business Overview
7.7.3 Yukon Medical Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Yukon Medical Closed Drug Transfer Systems Product Offerings
7.7.5 Yukon Medical Recent Developments
7.8 JMS
7.8.1 JMS Company Information
7.8.2 JMS Introduction and Business Overview
7.8.3 JMS Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 JMS Closed Drug Transfer Systems Product Offerings
7.8.5 JMS Recent Developments
7.9 Caragen Ltd.
7.9.1 Caragen Ltd. Company Information
7.9.2 Caragen Ltd. Introduction and Business Overview
7.9.3 Caragen Ltd. Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Caragen Ltd. Closed Drug Transfer Systems Product Offerings
7.9.5 Caragen Ltd. Recent Developments
7.10 Epic Medical
7.10.1 Epic Medical Company Information
7.10.2 Epic Medical Introduction and Business Overview
7.10.3 Epic Medical Closed Drug Transfer Systems Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Epic Medical Closed Drug Transfer Systems Product Offerings
7.10.5 Epic Medical Recent Developments
8 Industry Chain Analysis
8.1 Closed Drug Transfer Systems Industrial Chain
8.2 Closed Drug Transfer Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Closed Drug Transfer Systems Sales Model
8.5.2 Sales Channels
8.5.3 Closed Drug Transfer Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Closed Drug Transfer Systems market size was US$ 1136 million in 2025 and is forecast to reach a readjusted size of US$ 3583 million by 2032 with a CAGR of 18.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global Closed Drug Transfer Systems market was valued at US$ 1136 million in 2025 and is anticipated to reach US$ 3583 million by 2032, at a CAGR of 18.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 2900.00
(Single User License)
The global Closed Drug Transfer Systems market size was US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
The global Closed Drug Transfer Systems market is projected to grow from US$ 957 million in 2024 to US$ 3081 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 144
USD 4900.00
(Single User License)
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 3950.00
(Single User License)
The global market for Closed Drug Transfer Systems was valued at US$ 957 million in the year 2024 and is projected to reach a revised size of US$ 3081 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published Date: 2025-08-01
Pages: 79
USD 2900.00
(Single User License)
In 2024, the global market size of Closed Drug Transfer Systems was estimated to be worth US$ 1137 million and is forecast to reach approximately US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 106
USD 5900.00
(Single User License)
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1137 million in 2024 and is forecast to a readjusted size of US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 71
USD 3950.00
(Single User License)
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published Date: 2024-04-17
Pages: 131
USD 5600.00
(Single User License)
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published Date: 2024-04-16
Pages: 135
USD 5900.00
(Single User License)
The global Closed Drug Transfer Systems market size was US$ 1136 million in 2025 and is forecast to reach a readjusted size of US$ 3583 million by 2032 with a CAGR of 18.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global Closed Drug Transfer Systems market was valued at US$ 1136 million in 2025 and is anticipated to reach US$ 3583 million by 2032, at a CAGR of 18.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
The global Closed Drug Transfer Systems market size was US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
The global Closed Drug Transfer Systems market is projected to grow from US$ 957 million in 2024 to US$ 3081 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 144
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
The global market for Closed Drug Transfer Systems was valued at US$ 957 million in the year 2024 and is projected to reach a revised size of US$ 3081 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Published: 2025-08-01
Pages: 79
In 2024, the global market size of Closed Drug Transfer Systems was estimated to be worth US$ 1137 million and is forecast to reach approximately US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 106
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1137 million in 2024 and is forecast to a readjusted size of US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 71
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published: 2024-04-17
Pages: 131
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published: 2024-04-16
Pages: 135
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now